Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole M Haynes

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulationNicole M Haynes, Christopher D C Allen, Robin Lesley, et al.
The Journal of Experimental Medicine|November 15, 2006
Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropismKenji Kabashima, Nicole M Haynes, Ying Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2011
Eradication of solid tumors using histone deacetylase inhibitors combined with immune-stimulating antibodiesAilsa J Christiansen, Alison West, Kellie-Marie Banks, et al.
The Journal of Experimental Medicine|November 26, 2008
DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumorsSusan Gilfillan, Christopher J Chan, Marina Cella, et al.
Journal for Immunotherapy of Cancer|June 15, 2018
Immunomodulatory activities of pixatimod: emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitorsEdward Hammond, Nicole M Haynes, Carleen Cullinane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Toll-Like Receptor Triggering and T-Cell Costimulation Induce Potent Antitumor Immunity in MiceJennifer A Westwood, Nicole M Haynes, Janelle Sharkey, et al.
Cancer Research|April 17, 2008
Interleukin 21 enhances antibody-mediated tumor rejectionMark J Smyth, Michele W L Teng, Janelle Sharkey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
Rejection of syngeneic colon carcinoma by CTLs expressing single-chain antibody receptors codelivering CD28 costimulationNicole M Haynes, Joseph A Trapani, Michele W L Teng, et al.
Cancer Research|May 10, 2012
Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodiesInge Verbrugge, Jim Hagekyriakou, Leslie L Sharp, et al.
Blood|October 18, 2002
Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumorsNicole M Haynes, Joseph A Trapani, Michèle W L Teng, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulationNicole M Haynes, Christopher D C Allen, Robin Lesley, et al.
The Journal of Experimental Medicine|November 15, 2006
Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropismKenji Kabashima, Nicole M Haynes, Ying Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2011
Eradication of solid tumors using histone deacetylase inhibitors combined with immune-stimulating antibodiesAilsa J Christiansen, Alison West, Kellie-Marie Banks, et al.
The Journal of Experimental Medicine|November 26, 2008
DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumorsSusan Gilfillan, Christopher J Chan, Marina Cella, et al.
Journal for Immunotherapy of Cancer|June 15, 2018
Immunomodulatory activities of pixatimod: emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitorsEdward Hammond, Nicole M Haynes, Carleen Cullinane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Toll-Like Receptor Triggering and T-Cell Costimulation Induce Potent Antitumor Immunity in MiceJennifer A Westwood, Nicole M Haynes, Janelle Sharkey, et al.
Cancer Research|April 17, 2008
Interleukin 21 enhances antibody-mediated tumor rejectionMark J Smyth, Michele W L Teng, Janelle Sharkey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
Rejection of syngeneic colon carcinoma by CTLs expressing single-chain antibody receptors codelivering CD28 costimulationNicole M Haynes, Joseph A Trapani, Michele W L Teng, et al.
Cancer Research|May 10, 2012
Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodiesInge Verbrugge, Jim Hagekyriakou, Leslie L Sharp, et al.
Blood|October 18, 2002
Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumorsNicole M Haynes, Joseph A Trapani, Michèle W L Teng, et al.
Pageof 5